SANGAMO THERAPEUTICS, INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sangamo Therapeutics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
  • Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.07M, a 54.9% decline year-over-year.
  • Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $18.1M, a 41.9% decline year-over-year.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $27.4M, a 13.5% decline from 2022.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $31.7M, a 3.96% decline from 2021.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $33M, a 28.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $18.1M $3.07M -$3.73M -54.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $21.8M $2.72M -$5.56M -67.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $27.4M $6.11M -$2.14M -26% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $29.5M $6.19M -$1.6M -20.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $31.1M $6.79M -$1.13M -14.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $32.2M $8.28M +$586K +7.62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $31.7M $8.25M +$172K +2.13% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $31.5M $7.79M -$80K -1.02% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $31.6M $7.92M -$1.57M -16.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $33.1M $7.69M +$167K +2.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $33M $8.08M +$1.43M +21.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $31.5M $7.87M +$1.19M +17.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $30.3M $9.48M +$2.72M +40.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $27.6M $7.52M +$1.9M +33.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $25.7M $6.64M +$1.4M +26.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $24.3M $6.68M +$1.98M +42.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $22.3M $6.76M +$1.9M +39% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $20.4M $5.62M +$1.1M +24.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $19.3M $5.24M +$936K +21.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $18.4M $4.7M +$891K +23.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $17.5M $4.87M +$1.35M +38.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $16.2M $4.52M +$1.47M +48.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $14.7M $4.3M +$2.19M +103% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $12.5M $3.81M +$1.59M +71.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $10.9M $3.51M +$1.55M +78.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $9.35M $3.05M +$262K +9.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $9.09M $2.12M +$189K +9.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $8.9M $2.22M -$516K -18.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $9.42M $1.96M -$5.24M -72.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $14.7M $2.79M -$406K -12.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.1M $1.93M -$1.14M -37.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $16.2M $2.74M -$93K -3.29% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $16.3M $7.2M +$4.32M +150% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $12M $3.19M +$241K +8.16% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $11.7M $3.07M +$31K +1.02% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $11.7M $2.83M +$699K +32.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $11M $2.88M +$754K +35.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $10.2M $2.95M +$1.05M +54.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $9.2M $3.04M +$987K +48.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $8.21M $2.13M +$738K +53.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $7.48M $2.13M +$751K +54.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $6.72M $1.91M +$578K +43.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $6.15M $2.05M +$721K +54.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-18
Q3 2013 $5.43M $1.39M -$13K -0.93% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $5.44M $1.38M +$154K +12.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 $5.28M $1.33M -$54K -3.91% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $5.34M $1.33M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $1.4M -$648K -31.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $1.22M -$742K -37.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $1.38M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $2.05M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $1.97M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.